-Timothy J Kinsella Researcher Activity Profile

Research Author Detailed Information 

Timothy J Kinsella Publication Rate By Year

Timothy J Kinsella has published 8 paper(s) in 1949, 10 paper(s) in 2007, 4 paper(s) in 2008, for a total of 22 research publications in total.

Timothy J Tj Kinsella Author Information

LAST NAME: kinsella

FIRST NAME: Timothy J

INITIALS: tj

AFFILIATION:

Papers

Timothy J Kinsella's Publication Record

1. DNA mismatch repair initiates 6-thioguanine--induced autophagy through p53 activation in human tumor cells. Year Published: 2007
Department of Radiation Oncology, Case Western Reserve University and the Case Integrative Cancer Biology Program, Case Comprehensive Cancer Center/University Hospitals of Cleveland, Cleveland, Ohio 44106-6068, USA.
2. A novel role for DNA mismatch repair and the autophagic processing of chemotherapy drugs in human tumor cells. Year Published: 2007
Department of Radiation Oncology, Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, Ohio 44106-6068, USA.
3. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage. Year Published: 2007
Department of Radiation Oncology, Case Western Reserve University and Case Comprehensive Cancer Center/University Hospitals Case Medical Center, Cleveland, Ohio 44106-6068, USA.
4. 5-iodo-2-pyrimidinone-2'-deoxyribose-mediated cytotoxicity and radiosensitization in U87 human glioblastoma xenografts. Year Published: 2007
Department of Radiation Oncology, University Hospitals Case Medical Center, Cleveland, OH 44106-6068, USA. timothy.kinsella@UHhospitals.org
5. Probabilistic modeling of DNA mismatch repair effects on cell cycle dynamics and iododeoxyuridine-DNA incorporation. Year Published: 2007
Department of Electrical Engineering and Computer Science, Case Western Reserve University, and University Hospitals Case Medical Center, Cleveland, Ohio 44106-6068, USA.
6. Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) x 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization. Year Published: 2007
Department of Radiation Oncology, University Hospitals of Cleveland/Case Comprehensive Cancer Center, Cleveland, OH, USA.
7. 5-iodo-2-pyrimidinone-2'-deoxyribose-mediated cytotoxicity and radiosensitization in U87 human glioblastoma xenografts. Year Published: 2007
Department of Radiation Oncology, University Hospitals Case Medical Center, Cleveland, OH 44106-6068, USA. timothy.kinsella@UHhospitals.org
8. 5-iodo-2-pyrimidinone-2'-deoxyribose-mediated cytotoxicity and radiosensitization in U87 human glioblastoma xenografts. Year Published: 2007
Department of Radiation Oncology, University Hospitals Case Medical Center, Cleveland, OH 44106-6068, USA. timothy.kinsella@UHhospitals.org
9. Thoracic tumors. Year Published: 1949
10. Thoracoplasty in the treatment of pulmonary tuberculosis; an analysis of results 5 to 26 years after operation. Year Published: 1949
11. Skeletal traction in the treatment of traumatic anterior thoracic instability. Year Published: 1949
12. Bronchiectasis. Year Published: 1949
13. Thoracic tumors. Year Published: 1949
14. The diagnosis and treatment of carcinoma of the lung. Year Published: 1949
15. Skeletal traction in the treatment of traumatic anterior thoracic instability. Year Published: 1949
16. Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) x 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization. Year Published: 2007
Department of Radiation Oncology, University Hospitals of Cleveland/Case Comprehensive Cancer Center, Cleveland, OH, USA. timothy.kinsella@UHhospitals.org
17. Skeletal traction in the treatment of traumatic anterior thoracic instability. Year Published: 1949
18. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Year Published: 2008
Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109-2216, USA. klionsky@umich.edu
19. Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) x 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization. Year Published: 2007
Department of Radiation Oncology, University Hospitals of Cleveland/Case Comprehensive Cancer Center, Cleveland, OH, USA. timothy.kinsella@UHhospitals.org
20. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. Year Published: 2008
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 251 East Huron St, LC-178, Chicago, IL 60611, USA. wsmall@nmff.org
21. Mammalian target of rapamycin and S6 kinase 1 positively regulate 6-thioguanine-induced autophagy. Year Published: 2008
Department of Radiation Oncology, Case Western Reserve University, Case Comprehensive Cancer Center/University Hospitals Case Medical Center, Cleveland, OH 44106-6068, USA.
22. Mammalian target of rapamycin and S6 kinase 1 positively regulate 6-thioguanine-induced autophagy. Year Published: 2008
Department of Radiation Oncology, Case Western Reserve University, Case Comprehensive Cancer Center/University Hospitals Case Medical Center, Cleveland, OH 44106-6068, USA.